Development of long-acting nitrate delivery systems-Reference-Cited by-同舟云学术

Development of long-acting nitrate delivery systems

Published:1990-01 Issue:S1 Volume:38 Page:S15-S19
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Jonsson U. E.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF01417560.pdf

Reference30 articles.

1. Elbright GE (1914) The effects of nitroglycerin on those engaged in its manufacture. JAMA 62: 201?202

2. Needleman P, Lang S, Johnson EM (1972) Organic nitrates: relationship between biotransformation and rational angina pectoris therapy. J Pharmacol Exp Ther 181: 489?497

3. Thadani U, Fung HL, Darke AC, Parker JO (1982) Oral isosorbide dinitrate in angina pectoris: comparison of duration of action and dose-response relation during acute and sustained therapy. Am J Cardiol 49: 411?419

4. Flaherty JT (1989) Nitrate tolerance. A review of the evidence. Drugs 37: 523?550

5. Fung H-L, Chong S, Kowaluk E (1989) Mechanisms of nitrate action and vascular tolerance. Eur Heart J 10 [Suppl A]: 2?6

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High performance liquid chromatography–electrospray ionization mass spectrometric determination of isosorbide 5-mononitrate in human plasma;Journal of Chromatography B;2007-02

2. Isosorbide 5-Mononitrate;Drugs;1999

3. Reply to comments on `A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily and isosorbide dinitrate twice daily in patients with chronic stable angina';International Journal of Cardiology;1997-06

4. Comments on `A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily and isosorbide dinitrate twice daily in patients with stable angina';International Journal of Cardiology;1997-06

5. The plasma concentrations of isosorbide 5-mononitrate (5-ISMN) administered in an extended-release form to patients with acute myocardial infarction.;British Journal of Clinical Pharmacology;1995-06